Production (Stage)
CYduct Diagnostics, Inc.
CYDX
$0.2031
$0.0010.50%
OTC PK
| 03/31/2012 | 12/31/2011 | 09/30/2011 | 06/30/2011 | 03/31/2011 | |
|---|---|---|---|---|---|
| Revenue | 96.70K | 72.80K | 83.40K | 91.90K | 80.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 96.70K | 72.80K | 83.40K | 91.90K | 80.50K |
| Cost of Revenue | 36.50K | 22.20K | 25.50K | 50.50K | 36.70K |
| Gross Profit | 60.20K | 50.60K | 58.00K | 41.30K | 43.80K |
| SG&A Expenses | 129.50K | 91.10K | 275.10K | 219.80K | 531.00K |
| Depreciation & Amortization | -- | 0.00 | 2.00K | 5.00K | 5.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 166.00K | 113.30K | 302.60K | 275.30K | 572.60K |
| Operating Income | -69.30K | -40.50K | -219.10K | -183.40K | -492.10K |
| Income Before Tax | 131.10K | 117.90K | 73.90K | -186.40K | -509.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 131.10K | 117.90K | 73.90K | -186.40K | -509.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 131.10K | 117.90K | 73.90K | -186.40K | -509.20K |
| EBIT | -69.30K | -40.50K | -219.10K | -183.40K | -492.10K |
| EBITDA | -66.30K | -40.50K | -217.10K | -178.40K | -487.10K |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |